Tin-117m(4+)-DTPA for palliation of pain from osseous metastases: A pilot study
Journal Article
·
· Journal of Nuclear Medicine
OSTI ID:250037
- Brookhaven National Lab., Upton, NY (United States)
The physical and biological attributes of {sup 117m}Sn(4+)-DTPA indicate that it should be an effective agent for palliative therapy of painful bony metastatic disease. The aim of this study was to evaluate whether or not this agent could effectively reduce pain while sparing the hemopoietic marrow from adverse effects. Fifteen patients (10 males and 5 females) with painful bony metastases from various primary cancers were included in the study. Seven patients received 1.22 to 3.11 MBq/kg of {sub 117m}Sn intravenously (Group 1) and eight patients received 4.85 to 5.77 MBq/kg (Group 2). All but one were treated as outpatients and followed for a minimum of 2 mo. In the first group, pain relief was nonassessable in four patients because of death or additional treatment of soft-tissue disease by another modality. One patient had no relief of pain, one had complete relief of pain and one had transient relief of pain. No myelotoxicity was observed. For Group 2, three patients achieved complete relief of pain, two good relief, two partial relief and one began to experience pain relief when he suffered a pathological fracture 2 mo most-treatment. None of these patients had myelotoxicity. Tin-117m(4+)-DTPA can reduce pain from metastatic disease to bone without inducing adverse reactions related to bone marrow. Further studies are needed to assess tolerance levels for the bone marrow and to evaluate response rates and duration of effect. 6 refs., 4 figs., 4 tabs.
- Research Organization:
- Brookhaven National Laboratory (BNL), Upton, NY
- DOE Contract Number:
- AC02-76CH00016
- OSTI ID:
- 250037
- Journal Information:
- Journal of Nuclear Medicine, Journal Name: Journal of Nuclear Medicine Journal Issue: 5 Vol. 36; ISSN JNMEAQ; ISSN 0161-5505
- Country of Publication:
- United States
- Language:
- English
Similar Records
Palliation of bone pain with Sn-117m(4+)DTPA
Safety and efficacy parameters in patients treated with TiN-117m DTPA
Method for palliation of pain in human bone cancer using therapeutic tin-117m compositions
Journal Article
·
Sun May 01 00:00:00 EDT 1994
· Journal of Nuclear Medicine
·
OSTI ID:197909
Safety and efficacy parameters in patients treated with TiN-117m DTPA
Journal Article
·
Thu May 01 00:00:00 EDT 1997
· Journal of Nuclear Medicine
·
OSTI ID:563335
Method for palliation of pain in human bone cancer using therapeutic tin-117m compositions
Patent
·
Mon Dec 28 23:00:00 EST 1998
·
OSTI ID:872063